Related Experiment Video
Updated: Dec 1, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program
Kathryn T Bieging-Rolett1, Alyssa M Kaiser1, David W Morgens2
1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Abstract:
Although TP53 is the most commonly mutated gene in human cancers, the p53-dependent transcriptional programs mediating tumor suppression remain incompletely understood. Here, to uncover critical components downstream of p53 in tumor suppression, we perform unbiased RNAi and CRISPR-Cas9-based genetic screens in vivo. These screens converge upon the p53-inducible gene Zmat3, encoding an RNA-binding protein, and we demonstrate that ZMAT3 is an important tumor suppressor downstream of p53 in mouse KrasG12D-driven lung and liver cancers and human carcinomas. Integrative analysis of the ZMAT3 RNA-binding landscape and transcriptomic profiling reveals that ZMAT3 directly modulates exon inclusion in transcripts encoding proteins of diverse functions, including the p53 inhibitors MDM4 and MDM2, splicing regulators, and components of varied cellular processes. Interestingly, these exons are enriched in NMD signals, and, accordingly, ZMAT3 broadly affects target transcript stability. Collectively, these studies reveal ZMAT3 as a novel RNA-splicing and homeostasis regulator and a key component of p53-mediated tumor suppression.
Insights
Researchers identified Zmat3 (ZMAT3) as a crucial tumor suppressor gene downstream of TP53. ZMAT3 regulates RNA splicing and stability, impacting cancer cell growth and survival.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- TP53 is frequently mutated in human cancers, but its tumor-suppressive transcriptional targets are not fully understood.
- Identifying downstream effectors of p53 is critical for understanding cancer development and for developing targeted therapies.
Purpose of the Study:
- To uncover novel downstream targets of p53 involved in tumor suppression.
- To investigate the role of the p53-inducible gene Zmat3 (ZMAT3) in cancer.
Main Methods:
- Unbiased in vivo RNAi and CRISPR-Cas9 genetic screens were employed.
- Integrative analysis of ZMAT3's RNA-binding landscape and transcriptomic profiling was performed.
Main Results:
- Screens identified ZMAT3 as a key downstream effector of p53.
- ZMAT3 functions as a tumor suppressor in Kras-driven mouse lung/liver cancers and human carcinomas.
- ZMAT3 directly modulates exon inclusion, affecting transcripts of p53 inhibitors (MDM2, MDM4) and splicing regulators.
- ZMAT3 influences target transcript stability, particularly those with NMD signals.
Conclusions:
- ZMAT3 is a novel regulator of RNA splicing and homeostasis.
- ZMAT3 is a critical component of p53-mediated tumor suppression, offering potential therapeutic targets.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Gene Regulation During Sporulation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway

